B-Type Natriuretic Peptide Predicts Benefit From a Home-Based Nurse Care in Chronic Heart Failure

Journal of Cardiac Failure

Volumn 15, Issue 3, 2009, Pages 233-240

  Moertl, Deddo ^a   Berger, Rudolf ^a   Hammer, Alexandra ^a   Huelsmann, Martin ^a   Hutuleac, Raisa ^a   Pacher, Richard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

B type natriuretic peptide; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING CARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRIA; DISEASE PROGRESSION; DRUG UTILIZATION; FEMALE; HEART FAILURE; HOME CARE SERVICES; HOSPITALIZATION; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN;

EID: 62749156112     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2008.11.002     Document Type: Article

References (40)

1. McCullough P.A., Philbin E.F., Spertus J.A., et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 39 (2002) 60-69
2. Stewart S., MacIntyre K., Hole D.J., et al. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3 (2001) 315-322
3. Stewart A.L., Greenfield S., Hays R.D., et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 262 (1989) 907-913
4. Packer M., Fowler M.B., Roecker E.B., et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106 (2002) 2194-2199
5. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med 344 (2001) 1659-1667
6. Remme W.J., and Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22 (2001) 1527-1560
7. Komajda M., Follath F., Swedberg K., et al. The EuroHeart Failure Survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24 (2003) 464-474
8. Cleland J.G., Cohen-Solal A., Aguilar J.C., et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360 (2002) 1631-1639
9. Hunt S.A., Abraham W.T., Chin M.H., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112 (2005) e154-e235
10. Swedberg K., Cleland J., Dargie H., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
11. Stewart S., and Horowitz J.D. Home-based intervention in congestive heart failure: long-term implications on readmission and survival. Circulation 105 (2002) 2861-2866
12. Stromberg A., Martensson J., Fridlund B., et al. Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial. Eur Heart J 24 (2003) 1014-1023
13. Doust J.A., Pietrzak E., Dobson A., et al. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
14. Cleland J.G., Swedberg K., Follath F., et al. The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24 (2003) 442-463
15. Cleland J.G., Swedberg K., Cohen-Solal A., et al. The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2 (2000) 123-132
16. Remme W.J. The treatment of heart failure. Task Force of the Working Group on Heart Failure of the European Society of Cardiology. Eur Heart J 18 (1997) 736-753
17. McAlister F.A., Stewart S., Ferrua S., et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 44 (2004) 810-819
18. DeBusk R.F., Miller N.H., Parker K.M., et al. Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med 141 (2004) 606-613
19. Bettencourt P., Azevedo A., Pimenta J., et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
20. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
21. Stewart S., Marley J.E., and Horowitz J.D. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study. Lancet 354 (1999) 1077-1083
22. Kasper E.K., Gerstenblith G., Hefter G., et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol 39 (2002) 471-480
23. Blue L., Lang E., McMurray J.J., et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 323 (2001) 715-718
24. Rouleau J.L., Roecker E.B., Tendera M., et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J Am Coll Cardiol 43 (2004) 1423-1429
25. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316 (1987) 1429-1435
26. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327 (1992) 685-691
27. Deng M.C., De Meester J.M., Smits J.M., et al. Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 321 (2000) 540-545
28. Richards A.M., Doughty R., Nicholls M.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. J Am Coll Cardiol 37 (2001) 1781-1787
29. Richards A.M., Doughty R., Nicholls M.G., et al. Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group. Circulation 99 (1999) 786-792
30. Konstam M.A., Kronenberg M.W., Rousseau M.F., et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Circulation 88 (1993) 2277-2283
31. Remme W.J., Riegger G., Hildebrandt P., et al. The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN). Cardiovasc Drugs Ther 18 (2004) 57-66
32. Colucci W.S., Packer M., Bristow M.R., et al. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group. Circulation 94 (1996) 2800-2806
33. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation 104 (2001) 2996-3007
34. Thompson D.R., Roebuck A., and Stewart S. Effects of a nurse-led, clinic and home-based intervention on recurrent hospital use in chronic heart failure. Eur J Heart Fail 7 (2005) 377-384
35. Moyer-Knox D., Mueller T.M., Vuckovic K., et al. Remote titration of carvedilol for heart failure patients by advanced practice nurses. J Card Fail 10 (2004) 219-224
36. Packer M., Poole-Wilson P.A., Armstrong P.W., et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation 100 (1999) 2312-2318
37. Bristow M.R., Gilbert E.M., Abraham W.T., et al. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation 94 (1996) 2807-2816
38. Rich M.W., Gray D.B., Beckham V., et al. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 101 (1996) 270-276
39. Stewart S., and Horowitz J.D. Detecting early clinical deterioration in chronic heart failure patients post-acute hospitalisation-a critical component of multidisciplinary, home-based intervention?. Eur J Heart Fail 4 (2002) 345-351
40. Levy W.C., Mozaffarian D., Linker D.T., et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113 (2006) 1424-1433